Learn More
Medchemexpress LLC 4-[(Z)-[4-oxo-2-sulfanylidene-3-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazolidin-5-ylidene]methyl]benzoic acid | 1073612-91-5 | MFCD31619349 | 99.6% | 423.43 g/mol | C19H12F3NO3S2 | 100 MG

Supplier: Medchemexpress LLC HY103666100MG
CY-09 is a selective, direct inhibitor of the NLRP3 inflammasome used for biochemical and cellular research. It binds the ATP-binding motif of the NLRP3 NACHT domain and inhibits NLRP3 ATPase activity, preventing inflammasome assembly and activation. For research use only.
- Selective NLRP3 inhibitor targeting the NACHT domain
- Inhibits NLRP3 ATPase activity to block inflammasome activation
- High purity compound suitable for biochemical and cellular assays
- Available as a solid powder, stable under recommended storage conditions
- Supplied in research-scale pack sizes for laboratory experiments
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.